Latest BRO news and sentiment

Brown & Brown stock holds below target as Q2 2026 growth lags peers

Brown & Brown's stock is trading in the low $70s as of late August 2026, slightly below its consensus price target, despite a 30.4% increase in Q2 2026 revenue. However, its organic growth for the quarter was slightly negative (-0.7%), contrasting with mid-single-digit positive organic growth seen in several of its insurance broker peers. Analysts currently hold a consensus "Hold" rating on the stock, with a target price of $76.80, and the company is preparing for a 2-for-1 stock split on September 2, 2026.

Is Brown & Brown (BRO) Undervalued On Its Q2 Earnings Miss?

Brown & Brown (BRO) missed Q2 2026 earnings estimates, yet its stock has seen a 28.04% gain over the last quarter, despite a year-to-date and one-year decline. The company is considered undervalued based on intrinsic value and analyst targets, trading at a modest 3.8% discount to its fair value of $75.63, although its P/E ratio is higher than the US insurance industry average. Investors are advised to examine both the potential upsides and warning signs to assess the investment opportunity accurately.

Why Is Brown & Brown (BRO) Down 0.4% Since Last Earnings Report?

Shares of Brown & Brown (BRO) have declined 0.4% since its last earnings report, underperforming the S&P 500, prompting questions about its future trajectory. The company's Q2 2026 earnings of $1.07 per share missed Zacks Consensus Estimate by 0.9%, and revenues of $1.67 billion also missed expectations, despite a 30.4% year-over-year increase driven by acquisitions. Organic revenues, however, decreased by 0.7%, indicating challenges in core growth.

Coverys taps Brown & Brown wholesale veteran as chief underwriting officer

Coverys has appointed Walter Grote as chief underwriting officer, bringing over 35 years of experience in property and casualty and wholesale specialty lines. His appointment comes as the US medical professional liability market faces its second consecutive year of widening underwriting losses, with claims severity driving increased premiums and changes in available limits. Coverys, an MPL specialist insurer with an A ("Excellent") rating, aims to leverage Grote's expertise to support both near-term and longer-term growth amidst these market challenges.

Morgan Stanley Adjusts PT on Brown & Brown to $60 From $56, Keeps Underweight Rating

Brown & Brown Inc. stock underperforms Friday when compared to competitors

Brown & Brown Inc. (BRO) stock fell 1.49% on Friday, closing at $70.54, underperforming the broader market as the S&P 500 and Dow Jones also experienced declines. The company's shares are currently 28.24% below their 52-week high of $98.30, reached on August 20th. This performance was noted during an overall rough trading session.

BRO|Brown & Brown Inc|Price:71.150|Chg%:-0.460

This article provides a detailed overview of Brown & Brown Inc (BRO) stock, including its live price, market data, key financial figures, and analyst ratings. It highlights the company's profile as an insurance brokerage firm, its segment operations, and ownership structure. The data also includes current price performance, a stock score breakdown, and future earnings and revenue forecasts.